Commentary: Medicare must study unproven, expensive Alzheimer's drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective. |!| Portland
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective. |!| Portland